SWM
CVS icon

Sugarloaf Wealth Management’s CVS Health CVS Stock Holding History

Sugarloaf Wealth Management’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$65.8K Sell
1,466
-75
-5% -$4.21K 0.01% 272
2024
Q3 		$96.9K Buy
1,541
+13
+0.9% +$758 0.02% 238
2024
Q2 		$90.3K Buy
1,528
+11
+0.7% +$688 0.02% 237
2024
Q1 		$121K Sell
1,517
-122
-7% -$9.32K 0.03% 211
2023
Q4 		$129K Buy
1,639
+142
+9% +$10.1K 0.03% 192
2023
Q3 		$104K Buy
1,497
+9
+0.6% +$638 0.03% 206
2023
Q2 		$103K Buy
1,488
+10
+0.7% +$712 0.02% 204
2023
Q1 		$110K Sell
1,478
-31
-2% -$2.6K 0.03% 193
2022
Q4 		$141K Buy
1,509
+44
+3% +$4.25K 0.04% 156
2022
Q3 		$140K Buy
1,465
+7
+0.5% +$693 0.04% 159
2022
Q2 		$135K Buy
1,458
+6
+0.4% +$586 0.03% 156
2022
Q1 		$147K Buy
1,452
+5
+0.3% +$525 0.03% 152
2021
Q4 		$149K Buy
1,447
+6
+0.4% +$554 0.04% 157
2021
Q3 		$122K Buy
1,441
+7
+0.5% +$586 0.03% 168
2021
Q2 		$120K Buy
1,434
+7
+0.5% +$573 0.03% 167
2021
Q1 		$107 Hold
1,427
– – 0.03% 179
2020
Q4 		$97K Sell
1,427
-53
-4% -$3.45K 0.03% 176
2020
Q3 		$86K Hold
1,480
– – 0.03% 172
2020
Q2 		$96K Buy
1,480
+1
+0.1% +$63 0.04% 166
2020
Q1 		$88K Hold
1,479
– – 0.04% 164
2019
Q4 		$110K Buy
+1,479
New +$104K 0.05% 168

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Pzena Investment Management
Pzena Investment Management New York $30.8B AUM 11.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Sugarloaf Wealth Management's CVS Position: Q4 2024 in Review

Sugarloaf Wealth Management reduced its CVS Health (CVS) stake by 4.9% in Q4 2024, selling an estimated $4.21K and leaving 1,466 shares worth $65.8K. The position accounts for 0.01% of the portfolio, ranked #272.

Sugarloaf Wealth Management first reported a position in CVS in Q4 2019 and has held it in 21 quarters since. The position peaked at $149K in Q4 2021. 1,668 funds tracked by Wall St. Rank hold CVS as of Q4 2024.

  • Sugarloaf Wealth Management held 1,466 shares of CVS Health worth $65.8K as of Q4 2024.
  • Sugarloaf Wealth Management sold 75 CVS Health shares in Q4 2024, an estimated $4.21K.
  • CVS Health made up 0.01% of Sugarloaf Wealth Management's portfolio in Q4 2024, its #272 holding.
  • Sugarloaf Wealth Management first reported a position in CVS Health in Q4 2019 and has held it in 21 quarters since.
  • Sugarloaf Wealth Management's CVS Health position peaked at $149K in Q4 2021.
  • 1,668 funds tracked by Wall St. Rank held CVS Health as of Q4 2024.

Based on Sugarloaf Wealth Management's 13F filing for Q4 2024, filed 10 Jan 2025.